These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1999232)

  • 1. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease.
    Hof PR; Morrison JH
    Exp Neurol; 1991 Mar; 111(3):293-301. PubMed ID: 1999232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease.
    Hof PR; Nimchinsky EA; Celio MR; Bouras C; Morrison JH
    Neurosci Lett; 1993 Apr; 152(1-2):145-8. PubMed ID: 8515868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.
    Hof PR; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):55-64. PubMed ID: 1706358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonphosphorylated neurofilament protein and calbindin immunoreactivity in layer III pyramidal neurons of human neocortex.
    Hayes TL; Lewis DA
    Cereb Cortex; 1992; 2(1):56-67. PubMed ID: 1633408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer's disease.
    Mikkonen M; Alafuzoff I; Tapiola T; Soininen H; Miettinen R
    Neuroscience; 1999; 92(2):515-32. PubMed ID: 10408601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective loss of calbindin D28K-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study.
    Nishiyama E; Ohwada J; Iwamoto N; Arai H
    Neurosci Lett; 1993 Dec; 163(2):223-6. PubMed ID: 8309638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA neuronal subpopulations in cat primary auditory cortex: co-localization with calcium binding proteins.
    Hendry SH; Jones EG
    Brain Res; 1991 Mar; 543(1):45-55. PubMed ID: 2054675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of the calcium-binding proteins parvalbumin and calbindin-D28k in the sensorimotor cortex of the rat.
    van Brederode JF; Helliesen MK; Hendrickson AE
    Neuroscience; 1991; 44(1):157-71. PubMed ID: 1770994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calretinin-immunoreactive neurons in the normal human temporal cortex and in Alzheimer's disease.
    Fonseca M; Soriano E
    Brain Res; 1995 Sep; 691(1-2):83-91. PubMed ID: 8590068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease.
    Selden N; Geula C; Hersh L; Mesulam MM
    Neuroscience; 1994 Jun; 60(3):621-36. PubMed ID: 7523983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease.
    Hof PR; Cox K; Young WG; Celio MR; Rogers J; Morrison JH
    J Neuropathol Exp Neurol; 1991 Jul; 50(4):451-62. PubMed ID: 2061713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
    Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
    Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calbindin immunoreactivity in normal human temporal neocortex.
    Ferrer I; Tuñón T; Soriano E; del Rio A; Iraizoz I; Fonseca M; Guionnet N
    Brain Res; 1992 Feb; 572(1-2):33-41. PubMed ID: 1611533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of layer II neurons in human entorhinal cortex.
    Beall MJ; Lewis DA
    J Comp Neurol; 1992 Jul; 321(2):241-66. PubMed ID: 1500542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvalbumin- and calbindin-containing neurons express c-fos protein in primary and secondary (mirror) epileptic foci of the rat neocortex.
    Mihaly A; Szente M; Dubravcsik Z; Boda B; Kiraly E; Nagy T; Domonkos A
    Brain Res; 1997 Jun; 761(1):135-45. PubMed ID: 9247076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient expression of calbindin-D28k immunoreactivity in layer V pyramidal neurons during postnatal development of kitten cortical areas.
    Hogan D; Berman NE
    Brain Res Dev Brain Res; 1993 Aug; 74(2):177-92. PubMed ID: 8403381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer's disease.
    Riascos D; de Leon D; Baker-Nigh A; Nicholas A; Yukhananov R; Bu J; Wu CK; Geula C
    Acta Neuropathol; 2011 Nov; 122(5):565-76. PubMed ID: 21874328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calbindin-D28K-immunoreactive cells and fibres in the human amygdaloid complex.
    Sorvari H; Soininen H; Pitkänen A
    Neuroscience; 1996 Nov; 75(2):421-43. PubMed ID: 8931007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease.
    Hof PR; Perl DP; Loerzel AJ; Morrison JH
    Brain Res; 1991 Nov; 564(2):306-13. PubMed ID: 1810629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.